This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
6qgk
From Proteopedia
(Difference between revisions)
m (Protected "6qgk" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Structure of human Bcl-2 in complex with THIQ-phenyl pyrazole compound== | |
| - | + | <StructureSection load='6qgk' size='340' side='right'caption='[[6qgk]], [[Resolution|resolution]] 1.80Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[6qgk]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6QGK OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6QGK FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=J1Q:1-[2-[[(3~{S})-3-(aminomethyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]carbonyl]phenyl]-~{N},~{N}-dibutyl-5-methyl-pyrazole-3-carboxamide'>J1Q</scene></td></tr> | |
| - | [[Category: | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6qg8|6qg8]], [[6qgg|6qgg]], [[6qgh|6qgh]], [[6qgj|6qgj]]</td></tr> |
| - | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6qgk FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6qgk OCA], [http://pdbe.org/6qgk PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6qgk RCSB], [http://www.ebi.ac.uk/pdbsum/6qgk PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6qgk ProSAT]</span></td></tr> |
| + | </table> | ||
| + | == Disease == | ||
| + | [[http://www.uniprot.org/uniprot/BCL2_HUMAN BCL2_HUMAN]] Note=A chromosomal aberration involving BCL2 has been found in chronic lymphatic leukemia. Translocation t(14;18)(q32;q21) with immunoglobulin gene regions. BCL2 mutations found in non-Hodgkin lymphomas carrying the chromosomal translocation could be attributed to the Ig somatic hypermutation mechanism resulting in nucleotide transitions. | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/BCL2_HUMAN BCL2_HUMAN]] Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1).<ref>PMID:18570871</ref> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Casara, P]] | ||
[[Category: Chen, I]] | [[Category: Chen, I]] | ||
| - | [[Category: Williamson, D.S]] | ||
| - | [[Category: Smith, J]] | ||
| - | [[Category: Le Diguarher, T]] | ||
| - | [[Category: Matassova, N]] | ||
[[Category: Davidson, J]] | [[Category: Davidson, J]] | ||
| - | [[Category: Wang, Y]] | ||
| - | [[Category: Roughley, S]] | ||
| - | [[Category: Walmsley, C]] | ||
| - | [[Category: Graham, C.J]] | ||
| - | [[Category: Hubbard, R.E]] | ||
[[Category: Davis, B]] | [[Category: Davis, B]] | ||
| + | [[Category: Diguarher, T Le]] | ||
| + | [[Category: Dokurno, P]] | ||
| + | [[Category: Geneste, O]] | ||
| + | [[Category: Graham, C J]] | ||
| + | [[Category: Harris, R]] | ||
[[Category: Hickman, J]] | [[Category: Hickman, J]] | ||
| + | [[Category: Hubbard, R E]] | ||
| + | [[Category: Jordan, A M]] | ||
| + | [[Category: Kotschy, A]] | ||
| + | [[Category: Matassova, N]] | ||
| + | [[Category: Murray, J]] | ||
| + | [[Category: Pedder, C]] | ||
| + | [[Category: Ray, S]] | ||
| + | [[Category: Roughley, S]] | ||
| + | [[Category: Smith, J]] | ||
[[Category: Stark, J]] | [[Category: Stark, J]] | ||
| + | [[Category: Walmsley, C]] | ||
| + | [[Category: Wang, Y]] | ||
[[Category: Whitehead, N]] | [[Category: Whitehead, N]] | ||
| - | [[Category: | + | [[Category: Williamson, D S]] |
| - | [[Category: | + | [[Category: Apoptosis]] |
| - | [[Category: | + | [[Category: Bcl2]] |
| - | [[Category: | + | [[Category: Drug design]] |
| - | [[Category: | + | [[Category: Small molecule inhibitor]] |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
Structure of human Bcl-2 in complex with THIQ-phenyl pyrazole compound
| |||||||||||
Categories: Large Structures | Casara, P | Chen, I | Davidson, J | Davis, B | Diguarher, T Le | Dokurno, P | Geneste, O | Graham, C J | Harris, R | Hickman, J | Hubbard, R E | Jordan, A M | Kotschy, A | Matassova, N | Murray, J | Pedder, C | Ray, S | Roughley, S | Smith, J | Stark, J | Walmsley, C | Wang, Y | Whitehead, N | Williamson, D S | Apoptosis | Bcl2 | Drug design | Small molecule inhibitor
